Business Context and Reporting Period
This Form 8-K Current Report is filed by Lexaria Bioscience Corp. (Nasdaq: LEXX) on August 4, 2026. The report addresses a critical corporate governance event regarding the company's continued listing status on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock price rather than operational financial performance.
Material Changes
- Nasdaq Delisting Notification: On August 4, 2026, the company received notice from Nasdaq that it failed to regain compliance with Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00, within the 180-day compliance period.
- Reverse Stock Split: In anticipation of the notification, the company executed a reverse stock split on August 3, 2026.
- Current Trading Status: Following the split, shares are trading under CUSIP 52886N604 with a minimum bid price currently above the $1.00 requirement.
Outlook, Management Commentary, and Risks
Management has filed a request for a hearing and paid the requisite fee to suspend the delisting process. This action is intended to allow additional trading days to demonstrate sustained compliance with the bid price requirement. As of the filing date, the company expects to regain full compliance prior to any potential hearing and anticipates that its shares will continue trading on Nasdaq without interruption. The primary risk identified is the potential delisting if the company fails to maintain the minimum bid price during the appeal period.
Investor Verification Checklist
- Verify the current trading price of LEXX to ensure it remains above the $1.00 minimum bid price requirement.
- Confirm the status of the hearing request filed with Nasdaq and any subsequent rulings.
- Review the impact of the August 3, 2026 reverse stock split on share count and liquidity.
- Monitor for any further communications from Nasdaq regarding the suspension of the delisting notice.